We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.5%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$22.6B
AUM Growth
+$2.53B
(+13%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
8.58%
Top 10 Holdings %
Top 10 Hldgs %
35.91%
Holding
1,608
New
85
Increased
1,049
Reduced
367
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$128M |
| 2 |
Apple
AAPL
|
+$94.4M |
| 3 |
Li Auto
LI
|
+$71M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$68.4M |
| 5 |
Amazon
AMZN
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$55.4M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$37M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$28.3M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$22.5M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.39% |
| 2 | Consumer Discretionary | 9.2% |
| 3 | Communication Services | 8.23% |
| 4 | Healthcare | 6.97% |
| 5 | Financials | 5.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Immunocore
IMCR
$1.74B
| $43.9K | ﹤0.01% |
1,398
+285
| +26% | +$10.4K |
|
1327
Innoviva
INVA
$1.5B
| $43.7K | ﹤0.01% |
2,263
+399
| +21% | +$7.35K |
|
1328
Phathom Pharmaceuticals
PHAT
$743M
| $43.3K | ﹤0.01% |
2,470
+722
| +41% | +$10.1K |
|
1329
Cogent Biosciences
COGT
$6.47B
| $43.2K | ﹤0.01% |
3,959
+1,104
| +39% | +$10.7K |
|
1330
Maravai LifeSciences
MRVI
$861M
| $43.1K | ﹤0.01% |
5,120
+1,154
| +29% | +$9.98K |
|
1331
Lincoln Electric
LECO
$15.5B
| $42.9K | ﹤0.01% |
222
-23
| -9% | -$4.41K |
|
1332
monday.com
MNDY
$3.99B
| $42.7K | ﹤0.01% |
+157
| New | +$38.9K |
|
1333
Bruker
BRKR
$8.83B
| $42K | ﹤0.01% |
594
-57
| -9% | -$3.68K |
|
1334
TriNet
TNET
$3.22B
| $41.6K | ﹤0.01% |
432
+39
| +10% | +$3.88K |
|
|
CSR
1335
Centerspace
CSR
$939M
| $41.4K | ﹤0.01% |
579
+150
| +35% | +$10.8K |
|
1336
Enliven Therapeutics
ELVN
$4.25B
| $41.2K | ﹤0.01% |
1,708
+304
| +22% | +$7.04K |
|
|
JOYY
1337
JOYY Inc
JOYY
$3.64B
| $40.9K | ﹤0.01% |
1,085
-550
| -34% | -$18.9K |
|
|
CNTA
1338
DELISTED
Centessa Pharmaceuticals
CNTA
| $40.4K | ﹤0.01% |
2,556
+826
| +48% | +$10.1K |
|
1339
Woodward
WWD
$21.2B
| $39.9K | ﹤0.01% |
234
-26
| -10% | -$4.33K |
|
1340
Arcutis Biotherapeutics
ARQT
$3.25B
| $39.6K | ﹤0.01% |
4,228
+772
| +22% | +$7.62K |
|
|
GRFS
1341
Grifois
GRFS
$5.4B
| $39.5K | ﹤0.01% |
4,412
+770
| +21% | +$6.27K |
|
|
NXRT
1342
NexPoint Residential Trust
NXRT
$636M
| $39.1K | ﹤0.01% |
900
+232
| +35% | +$10.1K |
|
1343
Prothena Corp
PRTA
$466M
| $39K | ﹤0.01% |
1,945
+340
| +21% | +$7.31K |
|
|
IRBT
1344
DELISTED
iRobot
IRBT
| $39K | ﹤0.01% |
4,552
-307
| -6% | -$2.66K |
|
1345
Travere Therapeutics
TVTX
$5.79B
| $38.8K | ﹤0.01% |
2,767
+494
| +22% | +$5.15K |
|
1346
Churchill Downs
CHDN
$6.2B
| $38.6K | ﹤0.01% |
288
-29
| -9% | -$4.01K |
|
1347
Aurinia Pharmaceuticals
AUPH
$2.02B
| $37.7K | ﹤0.01% |
5,172
+902
| +21% | +$5.59K |
|
1348
Liberty Broadband Class C
LBRDK
$5.29B
| $37.6K | ﹤0.01% |
481
-47
| -9% | -$2.9K |
|
1349
Wave Life Sciences
WVE
$1.02B
| $37.4K | ﹤0.01% |
4,512
+856
| +23% | +$5.12K |
|
1350
Vir Biotechnology
VIR
$1.52B
| $37.2K | ﹤0.01% |
4,942
+880
| +22% | +$7.64K |
|
Similar funds
BC
Mirae Asset Global Investments's Q3 2024 Portfolio in Review
As of Q3 2024, Mirae Asset Global Investments held 1,608 positions worth $22.6B, up 13% from $20.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Mirae Asset Global Investments deployed $1.94B of net new capital in Q3 2024, opening 85 new positions and adding to 1,049 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 170,000 shares worth $15.5M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was NextEra Energy, an estimated $55.4M trimmed.
- Mirae Asset Global Investments's largest Q3 2024 buy was iShares MSCI USA Min Vol Factor ETF: 170,000 shares worth $15.5M.
- Mirae Asset Global Investments added most to Microsoft in Q3 2024, an estimated $128M increase.
- Mirae Asset Global Investments's biggest Q3 2024 reduction was NextEra Energy, cutting an estimated $55.4M.
- Mirae Asset Global Investments fully exited Axcelis in Q3 2024, selling an estimated $6.51M.
- Mirae Asset Global Investments's ten largest holdings make up 36% of its $22.6B portfolio in Q3 2024.
- Mirae Asset Global Investments opened 85 new positions and closed 57 in Q3 2024.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $22.6B.
Based on Mirae Asset Global Investments's 13F filing for Q3 2024, filed 23 Oct 2024.